The PCCTC-managed PROMISE Registry Manuscript Published In The Prostate.

The PROMISE Registry aims to provide access to germline genetic testing and to collect data to understand disease characteristics and treatment responses across the disease spectrum for prostate cancer with rare germline genetic variants.